Literature DB >> 17466567

CD36: implications in cardiovascular disease.

Maria Febbraio1, Roy L Silverstein.   

Abstract

CD36 is a broadly expressed membrane glycoprotein that acts as a facilitator of fatty acid uptake, a signaling molecule, and a receptor for a wide range of ligands, including apoptotic cells, modified forms of low density lipoprotein, thrombospondins, fibrillar beta-amyloid, components of Gram positive bacterial walls and malaria infected erythrocytes. CD36 expression on macrophages, dendritic and endothelial cells, and in tissues including muscle, heart, and fat, suggest diverse roles, and indeed, this is truly a multi-functional receptor involved in both homeostatic and pathological conditions. Despite an impressive increase in our knowledge of CD36 functions, in depth understanding of the mechanistic aspects of this protein remains elusive. This review focuses on CD36 in cardiovascular disease-what we know, and what we have yet to learn.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466567      PMCID: PMC2034445          DOI: 10.1016/j.biocel.2007.03.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  206 in total

Review 1.  Pattern recognition receptors: doubling up for the innate immune response.

Authors:  Siamon Gordon
Journal:  Cell       Date:  2002-12-27       Impact factor: 41.582

2.  CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails.

Authors:  N Tao; S J Wagner; D M Lublin
Journal:  J Biol Chem       Date:  1996-09-13       Impact factor: 5.157

3.  Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL.

Authors:  D Calvo; D Gómez-Coronado; Y Suárez; M A Lasunción; M A Vega
Journal:  J Lipid Res       Date:  1998-04       Impact factor: 5.922

4.  CD36 deficiency is frequent and can cause platelet immunization in Africans.

Authors:  K Lee; B Godeau; P Fromont; A Plonquet; N Debili; D Bachir; D Reviron; J Gourin; E Fernandez; F Galactéros; P Bierling
Journal:  Transfusion       Date:  1999-08       Impact factor: 3.157

5.  EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.

Authors:  Sylvie Marleau; Diala Harb; Kim Bujold; Roberta Avallone; Khadija Iken; Yanfei Wang; Annie Demers; Martin G Sirois; Maria Febbraio; Roy L Silverstein; André Tremblay; Huy Ong
Journal:  FASEB J       Date:  2005-08-25       Impact factor: 5.191

6.  Modulation of CD36 protein expression by AGEs and insulin in aortic VSMCs from diabetic and non-diabetic rats.

Authors:  Cristina de Oliveira Silva; Sandrine Delbosc; Caroline Araïs; Louis Monnier; Jean-Paul Cristol; Nuria Pares-Herbute
Journal:  Nutr Metab Cardiovasc Dis       Date:  2006-11-28       Impact factor: 4.222

Review 7.  Modulation of vascular smooth muscle signaling by reactive oxygen species.

Authors:  Alicia N Lyle; Kathy K Griendling
Journal:  Physiology (Bethesda)       Date:  2006-08

8.  Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36.

Authors:  Arend Bonen; Michelle L Parolin; Gregory R Steinberg; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; George J F Heigenhauser; David J Dyck
Journal:  FASEB J       Date:  2004-05-07       Impact factor: 5.191

9.  Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids.

Authors:  Hiroshi Irie; Irvin B Krukenkamp; Joep F F Brinkmann; Glenn R Gaudette; Adam E Saltman; William Jou; Jan F C Glatz; Nada A Abumrad; Azeddine Ibrahimi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-13       Impact factor: 11.205

10.  CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells.

Authors:  D W Dawson; S F Pearce; R Zhong; R L Silverstein; W A Frazier; N P Bouck
Journal:  J Cell Biol       Date:  1997-08-11       Impact factor: 10.539

View more
  84 in total

1.  oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms.

Authors:  Jingyi Ren; Wenying Jin; Hong Chen
Journal:  Mol Cell Biochem       Date:  2010-05-11       Impact factor: 3.396

2.  CD36 is involved in astrocyte activation and astroglial scar formation.

Authors:  Yi Bao; Luye Qin; Eunhee Kim; Sangram Bhosle; Hengchang Guo; Maria Febbraio; Renee E Haskew-Layton; Rajiv Ratan; Sunghee Cho
Journal:  J Cereb Blood Flow Metab       Date:  2012-04-18       Impact factor: 6.200

3.  Scavenger receptor CD36 mediates uptake of high density lipoproteins in mice and by cultured cells.

Authors:  May Brundert; Joerg Heeren; Martin Merkel; Antonella Carambia; Johannes Herkel; Peter Groitl; Thomas Dobner; Rajasekhar Ramakrishnan; Kathryn J Moore; Franz Rinninger
Journal:  J Lipid Res       Date:  2011-01-09       Impact factor: 5.922

4.  Nuclear factor-kappaB activation and postischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion.

Authors:  Alexander Kunz; Takato Abe; Karin Hochrainer; Munehisa Shimamura; Josef Anrather; Gianfranco Racchumi; Ping Zhou; Costantino Iadecola
Journal:  J Neurosci       Date:  2008-02-13       Impact factor: 6.167

Review 5.  Molecular regulation of tumor angiogenesis and perfusion via redox signaling.

Authors:  Thomas W Miller; Jeff S Isenberg; David D Roberts
Journal:  Chem Rev       Date:  2009-07       Impact factor: 60.622

Review 6.  Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors.

Authors:  K Kaarniranta; A Salminen
Journal:  J Mol Med (Berl)       Date:  2008-11-14       Impact factor: 4.599

Review 7.  Lipid transport in the lactating mammary gland.

Authors:  James L McManaman
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-02-25       Impact factor: 2.673

8.  Myeloid receptor CD36 is required for early phagocytosis of myocardial infarcts and induction of Nr4a1-dependent mechanisms of cardiac repair.

Authors:  Shirley Dehn; Edward B Thorp
Journal:  FASEB J       Date:  2017-08-31       Impact factor: 5.191

9.  Phytosterol-enriched yogurt increases LDL affinity and reduces CD36 expression in polygenic hypercholesterolemia.

Authors:  Gianluca Ruiu; Silvia Pinach; Fabrizio Veglia; Roberto Gambino; Saverio Marena; Barbara Uberti; Natalina Alemanno; Davina Burt; Gianfranco Pagano; Maurizio Cassader
Journal:  Lipids       Date:  2008-11-08       Impact factor: 1.880

Review 10.  Cellular fatty acid uptake: a pathway under construction.

Authors:  Xiong Su; Nada A Abumrad
Journal:  Trends Endocrinol Metab       Date:  2009-01-29       Impact factor: 12.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.